BHC
Bausch Health Companies Inc
NYSE: BHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.72
+2.33% today
Updated 2026-04-30
Market cap
$2.09B
P/E ratio
13.31
P/S ratio
0.20x
EPS (TTM)
$0.42
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Bausch Health Companies Inc (BHC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $521.93M | $340.85M | $204.32M | $360.90M | $263.19M | $676.47M | $656.58M | $1.04B | $2.29B | $2.20B | $2.09B | $2.29B | $1.50B | $1.50B | $1.11B | $1.43B | $-728.00M | $1.03B | $1.60B | $1.40B |
| Capital expenditures | $44.80M | $35.09M | $22.00M | $569.25M | $16.82M | $385.95M | $181.13M | $184.96M | $470.60M | $303.30M | $291.00M | $336.00M | $235.00M | $278.00M | $309.00M | $283.00M | $268.00M | $272.00M | $337.00M | $397.00M |
| Depreciation | $107.86M | $100.77M | $103.42M | $149.26M | $254.50M | $612.60M | $986.22M | $2.02B | $1.74B | $2.63B | $2.87B | $2.86B | $2.82B | $2.08B | $1.82B | $1.55B | $1.39B | $1.26B | $1.27B | $1.21B |
| Stock-based comp | — | — | $-5.73M | $5.61M | $98.03M | $94.02M | $66.24M | $45.48M | $78.20M | $140.10M | $165.00M | $87.00M | $87.00M | $102.00M | $105.00M | $128.00M | $126.00M | $132.00M | $150.00M | $216.00M |
| Free cash flow | $477.13M | $305.77M | $182.33M | $-208.35M | $246.37M | $290.52M | $475.44M | $857.00M | $1.82B | $1.90B | $1.80B | $1.95B | $1.27B | $1.22B | $802.00M | $1.14B | $-996.00M | $760.00M | $1.26B | $1.00B |
| Investing cash flow | $-40.45M | $-15.04M | $-107.83M | $-742.77M | $228.94M | $-2.84B | $-2.97B | $-5.38B | $-99.70M | $-15.58B | $-125.00M | $2.89B | $-196.00M | $-419.00M | $-261.00M | $409.00M | $-303.00M | $-2.15B | $-454.00M | $-595.00M |
| Financing cash flow | $-92.25M | $-728.65M | $-210.31M | $177.05M | $-213.28M | $1.95B | $3.06B | $4.03B | $-2.44B | $13.62B | $-1.96B | $-4.96B | $-1.35B | $1.44B | $-2.29B | $-1.51B | $-474.00M | $1.48B | $-868.00M | $-742.00M |
| Dividends paid | $80.06M | $321.52M | $180.29M | $147.15M | $356.29M | $52.50M | $0.00 | $8.48B | $8.20M | $17.86B | $9.00M | $18.00M | — | — | — | — | $31.00M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $279.81M | $-230.16M | $751.98M | $-315.75M | $-277.70M | $274.70M | $-55.00M | $255.00M | $-74.00M | $2.52B | $-1.44B | $322.00M | $-1.50B | — | — | — |